SCHEMBL18934858

SCHEMBL18934858

c1ccc(-n2c3ccccc3n3c4cc5c(cc4nc23)[nH]c2ccccc25)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.41
TOP2A P11388 1/20 0.39
PDE7A Q13946 2/20 0.37
PDE7B Q9NP56 2/20 0.37
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GPR3 P46089 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ATM Q13315 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KIF11 P52732 3/20 0.35
GABRP O00591 3/20 0.34
GABRD O14764 3/20 0.34
GABRA1 P14867 3/20 0.34
GABRB1 P18505 3/20 0.34
GABRG2 P18507 3/20 0.34
GABRB3 P28472 3/20 0.34
GABRA5 P31644 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18934354 0.95 AHR (0.41) AHRTOP2APDE7APDE7BADORA2B
SCHEMBL20616762 0.86 TOP2A (0.41) AHRTOP2APDE7APDE7BALDH1A1
SCHEMBL18934348 0.86 TOP2A (0.41) AHRTOP2APDE7APDE7BALDH1A1
SCHEMBL18687133 0.86 ADORA2B (0.35) AHRTOP2APDE7APDE7BADORA2B
SCHEMBL23652412 0.86 ADORA2B (0.35) AHRTOP2APDE7APDE7BADORA2B
SCHEMBL30876355 0.81 TOP2A (0.40) AHRTOP2AALDH1A1GPR3HSD17B10
SCHEMBL23219318 0.81 TOP2A (0.40) AHRTOP2AALDH1A1GPR3HSD17B10
SCHEMBL12800982 0.81 TOP2A (0.40) AHRTOP2AALDH1A1GPR3HSD17B10
SCHEMBL18934567 0.81 ADORA2B (0.45) ADORA2BADORA1ALDH1A1HSD17B10KDM4E
SCHEMBL18698129 0.80 HPGD (0.37) AHRTOP2APDE7APDE7BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2021-11-16 US disclosed
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-01-03 US disclosed
WO-2017093958-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2017-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes KCNH2, KCNH3, KCNJ2 AHR 2264/4885TOP2A 2653/4885PDE7A 3469/4885
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES KCNH2, KCNH3, KCNJ2 AHR 2264/4885TOP2A 2653/4885PDE7A 3469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.